Aldosterone synthase inhibitor is a highly anticipated drug for cardio-metabolic indications. The drug will selectively inhibit synthesis of hormone aldosterone to manage deleterious effects of its overproduction.

Discovery of the novel drug for treatment of tuberculosis infection.

Early drug discovery in multiple targets/indications.